Cargando…
Effects of Axonal Ion Channel Dysfunction on Quality of Life in Type 2 Diabetes
OBJECTIVE: Pharmacological agents for diabetic peripheral neuropathy (DN) target a number of mechanisms, including sodium channel function and γ-aminobutyric acid–minergic processes. At present, prescription is undertaken on a trial-and-error basis, leading to prolonged medication trials and greater...
Autores principales: | Kwai, Natalie C.G., Arnold, Ria, Wickremaarachchi, Chathupa, Lin, Cindy S.-Y., Poynten, Ann M., Kiernan, Matthew C., Krishnan, Arun V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3631837/ https://www.ncbi.nlm.nih.gov/pubmed/23404298 http://dx.doi.org/10.2337/dc12-1310 |
Ejemplares similares
-
Progressive Axonal Dysfunction Precedes Development of Neuropathy in Type 2 Diabetes
por: Sung, Jia-Ying, et al.
Publicado: (2012) -
The Relationship between Dyslipidemia and Acute Axonal Function in Type 2 Diabetes Mellitus In Vivo
por: Kwai, Natalie C. G., et al.
Publicado: (2016) -
Chronic Kidney Disease Has No Impact on Tear Film Substance P Concentration in Type 2 Diabetes
por: Asiedu, Kofi, et al.
Publicado: (2023) -
Diagnostic accuracy of nerve ultrasonography for the detection of peripheral neuropathy in type 2 diabetes
por: Dhanapalaratnam, Roshan, et al.
Publicado: (2022) -
Peripheral nerve morphology and intraneural blood flow in chronic kidney disease with and without diabetes
por: Issar, Tushar, et al.
Publicado: (2022)